Prevalent Oral Drug Delivery System for Dental Care

Amanda      Frank; Komal      Singh; Preet Amol      Singh; Neha      Bajwa

doi:10.2174/012542579X258065231114102420

Abstract

Oral drug delivery systems, including fluoride supplements, constitute one of the most prevalent routes for the administration of medications, playing a crucial role in the treatment and prevention of various diseases, including dental caries. Fluorides, employed as a preventive and control measure against dental caries, are available in two primary forms: Systemic fluorides and topical fluorides. Topical fluorides are found in toothpaste, varnish, gels, mouth rinses, and washes, while systemic fluorides are administered via lozenges, tablets, and liquid formulations.

This literature work focuses on the specific challenges associated with fluoride supplement formulations and aims to shed light on potential setbacks. Among these challenges, poor patient compliance, especially in pediatric populations, and the associated risk of underdosing or overdosing, leading to fluorosis, stand out as significant concerns. If left unaddressed, these issues could compromise the efficacy of one of the most effective caries prevention methods available.

The primary objective of this study is to explore advancements in fluoride supplement formulations, with a particular emphasis on addressing the identified challenges, especially for pediatric and geriatric patients. By devising improved formulations tailored to the unique needs of these populations, we aim to mitigate compliance issues and minimize the associated risk factors, thereby strengthening the effectiveness of dental caries prevention strategies. This research endeavors to contribute valuable insights to the field of oral healthcare and pharmaceutical development, ultimately promoting better oral health outcomes for individuals of all ages.

Keywords: Fluoride supplements, chewable tablets, lozenges, liquid formulations, fluorosis, tooth decay.

[1]
Sunil S, Sharma K AS. Pharmaceutical Jellies: A novel way of drug delivery. J Pharm Sci Res  2020; 12(7): 904-9.

[2]
Hellwig E, Lennon ÁM. Systemic versus topical fluoride. Caries Res  2004; 38(3): 258-62.
 [http://dx.doi.org/10.1159/000077764] [PMID: 15153698]

[3]
Maniruzzaman M, Boateng JS, Chowdhry BZ, Snowden MJ, Douroumis D. A review on the taste masking of bitter APIs: Hot-melt extrusion (HME) evaluation. Drug Dev Ind Pharm  2014; 40(2): 145-56.
 [http://dx.doi.org/10.3109/03639045.2013.804833] [PMID: 23763436]

[4]
Riordan PJ. Fluoride supplements for young children: An analysis of the literature focusing on benefits and risks. Community Dent Oral Epidemiol  1999; 27(1): 72-83.
 [http://dx.doi.org/10.1111/j.1600-0528.1999.tb01994.x] [PMID: 10086929]

[5]
Montero-Padilla S, Velaga S, Morales JO. Buccal dosage forms: General considerations for pediatric patients. AAPS PharmSciTech  2017; 18(2): 273-82.
 [http://dx.doi.org/10.1208/s12249-016-0567-2] [PMID: 27301872]

[6]
Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: Final results after eight years. J Public Health Dent  1992; 52(2): 111-6.
 [http://dx.doi.org/10.1111/j.1752-7325.1992.tb02252.x] [PMID: 1564689]

[7]
Negi P, Singh B, Sharma G, Beg S, Katare OP. Biocompatible lidocaine and prilocaine loaded-nanoemulsion system for enhanced percutaneous absorption: QbD-based optimisation, dermatokinetics and in vivo evaluation. J Microencapsul  2015; 32(5): 419-31.
 [http://dx.doi.org/10.3109/02652048.2015.1046513] [PMID: 26066775]

[8]
Psimadas D, Georgoulias P, Valotassiou V, Loudos G. Molecular nanomedicine towards cancer: In-labeled nanoparticles. J Pharm Sci  2012; 101(7): 2271-80.
 [http://dx.doi.org/10.1002/jps.23146] [PMID: 22488174]

[9]
Dahiya J, Jalwal P, Singh B. Chewable tablets: A comprehensive review. Pharma Innov J  2015; 4(5): 100-5.

[10]
Ray C, Arora V, Sharma V. Fast dissolving tablets-a novel drug delivery system for pediatric & geriatric patient. Int Bulletin Drug Res  2011; 1(2): 55-70.

[11]
Udaykumar M, Nageswarao AB, Kumar VT, Giri VV. Fast dissolving tablets: New fangled drug delivery system, a comprehensive review. Int J Drug Deliv  2012; 2(3): 15-8.

[12]
Lopez FL, Ernest TB, Tuleu C, Gul MO. Formulation approaches to pediatric oral drug delivery: Benefits and limitations of current platforms. Expert Opin Drug Deliv  2015; 12(11): 1727-40.
 [http://dx.doi.org/10.1517/17425247.2015.1060218] [PMID: 26165848]

[13]
Covariance structure analysis on health-related indicators in homebound elderly individuals with a focus on the UMDECDE. 2015.

[14]
Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol  1955; 8(2): 213-6.
 [http://dx.doi.org/10.1016/0030-4220(55)90195-X] [PMID: 13236309]

[15]
Heilig ML. United States patent office. ACM SIGGRAPH Comput Graph 1994; 28(2): 131-4.

Rights & Permissions Print Cite

Article Metrics

17

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/012542579X258065231114102420	Print ISSN 2542-579X
Publisher Name Bentham Science Publisher	Online ISSN 2542-5803

Current Dentistry

Prevalent Oral Drug Delivery System for Dental Care

Abstract

Related Journals

Related Books